---
title: "Goldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294017848.md"
description: "Goldman Sachs analyst Rajan Sharma reaffirmed a Buy rating on AstraZeneca (AZN) with a price target of £16,070.00. This follows a recent Buy recommendation from Berenberg Bank's Luisa Hector, contrasting with Deutsche Bank's maintained Sell rating issued on July 15."
datetime: "2026-07-28T05:35:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294017848.md)
  - [en](https://longbridge.com/en/news/294017848.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294017848.md)
---

# Goldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)

In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca, with a price target of p16,070.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Sharma covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Immatics. According to TipRanks, Sharma has an average return of 3.1% and a 54.46% success rate on recommended stocks.

In addition to Goldman Sachs, AstraZeneca also received a Buy from Berenberg Bank’s Luisa Hector in a report issued yesterday. However, on July 15, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [IMTX.US](https://longbridge.com/en/quote/IMTX.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)
- [IMTXW.US](https://longbridge.com/en/quote/IMTXW.US.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [CSPC Sees Profit Surge on AstraZeneca Deal and Solid Drug Sales](https://longbridge.com/en/news/293910247.md)
- [AstraZeneca, Bristol Myers Squibb Hold Early Merger Talks for Potential $400B Deal](https://longbridge.com/en/news/294650415.md)
- [AstraZeneca’s Etcamah-CDK4/6 combo wins EU approval for 1st-line advanced ER-positive breast cancer](https://longbridge.com/en/news/293566585.md)
- [AstraZeneca plots £300bn tie-up with US rival](https://longbridge.com/en/news/294613433.md)
- [AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, FT reports](https://longbridge.com/en/news/294612509.md)